ACTIVITY AND SAFETY OF A COMBINATION OF EPIRUBICIN, DOCETAXEL AND CISPLATIN AS NEOADJUVANT TREATMENT FOR LOCALLY ADVANCED BREAST CANCER (LABC): A PRELIMINARY REPORT

被引：0
|
作者：
Avci, N. [1 ]
Kanat, O. [1 ]
Gokgoz, S. [1 ]
Tolunay, S. [1 ]
Topal, U. [1 ]
Cubukcu, E. [1 ]
Olmez, F. [1 ]
机构：
[1] Uludag Univ, Fac Med, Bursa, Turkey
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [1] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [2] Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).
    Puerto, VL
    Cardenas, J
    Lara, F
    Goana, R
    Silva, A
    Barroso, N
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 299 - 299
  • [3] The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer
    Hirano, A
    Shimizu, T
    Imamura, H
    Watanabe, O
    Kinoshita, J
    Okabe, T
    Kimura, K
    Kamimura, M
    Domoto, K
    Aiba, M
    Ogawa, K
    [J]. ANTICANCER RESEARCH, 2006, 26 (1B) : 581 - 584
  • [4] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, D.
    Scalone, S.
    Crivellari, D.
    La Mura, N.
    Miolo, G.
    Murrone, A.
    Perin, T.
    Coran, F.
    Candiani, E.
    Massarut, S.
    Veronesi, A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [5] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, Davide
    Scalone, Simona
    Crivellari, Diana
    Magri, Maria Donatella
    La Mura, Nicoletta
    Miolo, GianMaria
    Murrone, Antonio
    Perin, Tiziana
    Coran, Francesco
    Candiani, Ezio
    Massarut, Samuele
    Veronesi, Andrea
    [J]. TUMORI JOURNAL, 2010, 96 (02): : 229 - 233
  • [6] A different yet traditional approach to neoadjuvant treatment of breast cancer: The combination of epirubicin and docetaxel Neoadjuvant epirubicin docetaxel in breast cancer'
    Yuce, Elif
    Karakullukcu, Serdar
    Alandag, Celal
    Bulbul, Hatice
    Saygin, Ismail
    Kavgaci, Halil
    [J]. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14
  • [7] NEOADJUVANT 3-WEEKLY EPIRUBICIN (EPI) PLUS DOCETAXEL (DOC) CHEMOTHERAPY (CT) IN LOCALLY ADVANCED BREAST CANCER (LABC): ACTIVITY, SAFETY AND PREDICTIVE FACTORS OF RESPONSE
    Strada, Maria Rosa
    Frascaroli, Mara
    Palumbo, Raffaella
    Bernardo, Antonio
    Villani, Laura
    Scelsi, Mario
    Jedrychowska, Ivona
    Albanese, Davide
    Teragni, Cristina
    Bernardo, Giovanni
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [8] Improved efficacy in the neoadjuvant treatment of locally advanced breast cancer (LABC)
    Smolanka, I. I.
    Lygyrda, O. F.
    Galakhin, K. A.
    Kudrjavetz, Y. J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 134 - 134
  • [9] A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Fried, G
    Zidan, J
    Epelbaum, R
    Keren-Rosenberg, S
    Basher, W
    Steckelman, I
    Kogan, F
    Haim, N
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S69 - S70
  • [10] Locally advanced breast cancer (LABC): Neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC).
    Wynendaele, W
    Paridaens, R
    Wildiers, J
    Christiaens, MR
    Van den Bogaert, W
    van Oosterom, AT
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S208 - S208
12345